Washington Post National Health Reporter Paige Winfield Cunningham discusses how the Trump administration is considering ...

According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

A move to cover expensive weight-loss drugs for Americans on Medicare and Medicaid may be in the works, but any such program ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

The federal government's Medicare program and older adults together spend $4.4 billion a year on care that has low clinical ...

Thousands of Rhode Island seniors and disabled residents no longer covered for non-emergency visits at four local hospitals ...

A new study reveals that Medicare beneficiaries are receiving billions of dollars worth of medical care that offer little to no clinical benefit and may lead to harm. Researchers found that Medicare ...

A new study finds Medicare pays billions annually for low-value tests and treatments. See which procedures waste the most and ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.